Novel coronavirus information

Fall 2020 update  |  FAQ page  |  Class flexibility for students  |  Novel coronavirus updates

Paul Whiteaker


Dr. Paul Whiteaker has over two decades of experience working in nicotinic acetylcholine receptor research. He has provided original insights that have helped to define the subunit composition and functional and ligand-binding pharmacology of naturally expressed nicotinic receptor subtypes. More information on Barrow Neurological Institute site.